Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells
- 1 November 2014
- journal article
- Published by Elsevier in Toxicology Letters
- Vol. 231 (1) , 55-61
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81272713)
- Technology Development Fund of Nanjing Medical University (2013NJMU021)
This publication has 29 references indexed in Scilit:
- The Inflammatory Microenvironment in Hepatocellular Carcinoma: A Pivotal Role for Tumor-Associated MacrophagesBioMed Research International, 2012
- Comparison of Optical and Power Doppler Ultrasound Imaging for Non-Invasive Evaluation of Arsenic Trioxide as a Vascular Disrupting Agent in TumorsPLOS ONE, 2012
- Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer developmentHepatology, 2012
- Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalkBreast Cancer Research, 2012
- IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinomaMolecular Cancer, 2011
- Hepatocellular carcinoma with extrahepatic metastasisCancer, 2011
- Anti–Transforming Growth Factor β Receptor II Antibody Has Therapeutic Efficacy against Primary Tumor Growth and Metastasis through Multieffects on Cancer, Stroma, and Immune CellsClinical Cancer Research, 2010
- The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-β signalingJournal of Clinical Investigation, 2009
- Inhibition of cell proliferation and the action mechanisms of arsenic trioxide (As2O3) on human breast cancer cellsJournal of Cellular Biochemistry, 2004
- TGFβ/Smad signaling system and its pathologic correlatesAmerican Journal of Medical Genetics Part A, 2002